Presence of the latent membrane protein 1 gene in nasopharyngeal swabs from patients with mucosal recurrent nasopharyngeal carcinoma
β Scribed by Ngan-Ming Tsang; Chi-Cheng Chuang; Chen-Kan Tseng; Sheng-Po Hao; Tseng-Tong Kuo; Chien-Yu Lin; Ping-Ching Pai
- Publisher
- John Wiley and Sons
- Year
- 2003
- Tongue
- English
- Weight
- 119 KB
- Volume
- 98
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
β¦ Synopsis
Background:
Nasopharyngeal carcinoma (npc) is the most common head and neck malignancy in southeastern china and taiwan. early detection of the local disease followed by timely and appropriate treatment is essential to increasing cure and survival rates. detection of epstein-barr virus (ebv) genomic dna, such as the latent membrane protein 1 gene (lmp-1), in patients postirradiation during follow-up may indicate mucosal recurrence.
Methods:
Seventy-one patients with npc underwent serial nasopharyngeal swabs for lmp-1 polymerase chain reaction assay before, during, and after irradiation. all of patients achieved a complete disease remission of the lmp-1 gene after irradiation that lasted for at least 6 months.
Results:
The median lmp-1 disease remission time after the beginning of irradiation was 4.3 weeks. patients with early lmp-1 disease remission ( 4 weeks) had 3-year local control rates of 93.5% and 76.9%, respectively (p = 0.0529). the lmp-1 gene was detected again (reexpression of lmp-1 [re-lmp-1]) in 10 patients after irradiation with at least 6 months of follow-up. nine of 10 patients (90%) in the re-lmp-1 positive group and 2 of 61 patients (3.3%) in the re-lmp-1 negative group developed local recurrence. mucosal recurrence developed in nine patients, and all displayed re-lmp-1. by detecting re-lmp-1 using nasopharyngeal swabs, mucosal recurrence was diagnosed with a sensitivity of 100% (9 of 9 patients) and a specificity of 98.4% (61 of 62 patients). the 3-year overall survival rate, the disease free survival rate for the entire group, and the estimated local mucosal control rates in the re-lmp-1 positive and re-lmp-1 negative groups were 86.5%, 76.5%, 19.4%, and 96.7%, respectively.
Conclusions:
Expression of ebv lmp-1 in nasopharyngeal swab specimens from patients with irradiated/treated npc can provide a highly sensitive and specific method of forecasting mucosal recurrence. this investigation confirmed the reliability and feasibility of nasopharyngeal swabs in screening for mucosal recurrences in patients with npc.
π SIMILAR VOLUMES
## Abstract ## BACKGROUND Nasopharyngeal carcinoma (NPC) is a common head and neck cancer in Taiwan. The goals of the current study were to investigate whether a nasopharyngeal swab technique could provide enough DNA for polymerase chain reaction (PCR) analysis of the EpsteinβBarr virus (EBV)βderi
We reported previously that a characteristic Epstein-Barr virus latent membrane protein 1 (EBV-LMP1) gene was associated with nasopharyngeal carcinoma (NPC) in Hong Kong. It showed a 30 bp deletion at the carboxyl terminus with specific amino acid substitution Asp at codon 335 with reference to Gly
## Abstract Latent membrane protein 1 (LMPβ1) is an EpsteinβBarr virusβencoded oncoprotein expressed in βΌ50β70% of nasopharyngeal carcinoma (NPC). Previous studies have shown that NPCβderived LMPβ1 variants carrying 30 bp deletion and specific mutations in the 3β²Cβterminal region confer high oncoge
## Abstract Although activating proteinβ1 (APβ1) transcription factors play an important role in mediating metastasis for nasopharyngeal carcinoma (NPC), the biological and physiological functions of APβ1, in relation to the oncogenic phenotype of NPC, are not fully understood. Our previous study s